Cel
The ABIRISK project provides an integrated approach to the study of immunization against biopharmaceuticals, bringing together a unique panel of experts from different disciplines.
ABIRISK will involve many of the European leaders in rheumatology, gastroenterology, hemophilia and multiple sclerosis, caring for ~30,000 patients treated with biopharmaceuticals, with ~10,000 additional patients recruited per year. This should lead to the constitution of the largest possible cohort in Europe for the study of immunogenicity, a condition critical for the success of the program. ABIRISK will also benefit from the unique expertise of immunologist partners in the development of innovative strategies for predicting the immunogenicity of biopharmaceuticals and for defining its mechanisms. The large number of patients enrolled in the ABIRISK cohorts should make it possible to study the genetic basis of immunogenicity in a new way.
We will standardize all clinical and biological information before its integration into a large database for evaluation of the clinical relevance of immunization against biopharmaceuticals and stratification of the risk to patients as a function of factors linked to treatment or to the individual. Computational biology and biostatistical modeling will be used to develop models for predicting immunogenicity that will be validated with the ABIRISK database.
The complementarity between the clinical partners from different disciplines, immunologists, methodologists and biostatisticians will create a unique task force for studies of biopharmaceutical immunogenicity. The direct outcomes of the proposed work will be greater understanding of the mechanisms involved in the emergence of anti-drug antibodies, the development of new methods for predicting immunogenicity and a comprehensive view of the respective value of predictive tools, and guidelines for the development of new biopharmaceuticals and patient care.
Dziedzina nauki
- medical and health sciencesclinical medicinerheumatology
- natural sciencescomputer and information sciencesdatabases
- medical and health sciencesbasic medicineimmunologyimmunisation
- medical and health sciencesbasic medicineneurologymultiple sclerosis
- medical and health sciencesclinical medicinegastroenterology
Zaproszenie do składania wniosków
IMI-JU-03-2010
Zobacz inne projekty w ramach tego zaproszenia
System finansowania
JTI-CP-IMI - Joint Technology Initiatives - Collaborative Project (IMI)Koordynator
4056 Basel
Szwajcaria
Zobacz na mapie
Uczestnicy (37)
75654 Paris
Zobacz na mapie
50121 Florence
Zobacz na mapie
6500 Bellinzona
Zobacz na mapie
75015 PARIS 15
Zobacz na mapie
DK-2100 Copenhagen
Zobacz na mapie
WC1E 6BT London
Zobacz na mapie
2333 ZA Leiden
Zobacz na mapie
1105AZ Amsterdam
Zobacz na mapie
16147 Genova
Zobacz na mapie
75010 Paris
Zobacz na mapie
31096 Haifa
Zobacz na mapie
53127 Bonn
Zobacz na mapie
63225 Langen
Zobacz na mapie
60323 Frankfurt Am Main
Zobacz na mapie
17177 Stockholm
Zobacz na mapie
6020 Innsbruck
Zobacz na mapie
40225 Dusseldorf
Zobacz na mapie
3400 Hillerod
Zobacz na mapie
4031 Basel
Zobacz na mapie
08035 Barcelona
Zobacz na mapie
E1 4NS London
Zobacz na mapie
81675 Muenchen
Zobacz na mapie
75794 Paris
Zobacz na mapie
53100 Siena
Zobacz na mapie
68167 Mannheim
Zobacz na mapie
116 36 Praha 1
Zobacz na mapie
CT13 9NJ Sandwich
Zobacz na mapie
TW89GS Brentford
Zobacz na mapie
1070 Bruxelles / Brussel
Zobacz na mapie
94250 GENTILLY
Zobacz na mapie
64293 Darmstadt
Zobacz na mapie
2880 Bagsvaerd
Zobacz na mapie
13353 Berlin
Zobacz na mapie
91940 Les Ulis
Zobacz na mapie
52621 Ramat Gan
Zobacz na mapie
54123 SKOVDE
Zobacz na mapie
75012 Paris
Zobacz na mapie